C12N 2502/1107
B cells
C12N2502/1107 (B cells) appears on 40 US grants and 87 published applications in this corpus.
Search patents in C12N- Granted patents
- 40
- Published applications
- 87
- Assignees
- 62
- Inventors
- 164
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 3 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 3 | 3 |
| 2011 | 5 | 3 |
| 2012 | 3 | 2 |
| 2013 | 0 | 3 |
| 2014 | 3 | 2 |
| 2015 | 1 | 2 |
| 2016 | 1 | 3 |
| 2017 | 4 | 2 |
| 2018 | 2 | 7 |
| 2019 | 2 | 7 |
| 2020 | 1 | 11 |
| 2021 | 3 | 4 |
| 2022 | 2 | 8 |
| 2023 | 1 | 6 |
| 2024 | 3 | 7 |
| 2025 | 2 | 4 |
| 2026 | 4 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for transduction of t cells in the presence of malignant cells4 Aug 2026US 12,698,315 B2Miltenyi Biotec GmbH
- B-cell cultivation method4 Aug 2026US 12,698,474 B2Hoffmann-La Roche Inc.
- Methods for treating an immune disorder-related disease by reducing autoreactivity in a T cell compartment9 Jun 2026US 12,649,905 B2Hackensack University Medical Center
- Production of a bioengineered lung28 Apr 2026US 12,612,602 B2Board of Regents, The University of Texas System
- Expansion of natural killer and chimeric antigen receptor-modified cells28 Oct 2025US 12,453,773 B2Houston Methodist Hospital
- Cancer models1 Oct 2026US 2026/0297534 A1Carcinotech Ltd
- Method for Producing a Three-Dimensional Human Multiple-Myeloma Model7 May 2026US 2026/0125654 A1Centre Hospitalier Universitaire De Toulouse
- Method of treating alzheimer's disease with expanded natural killer cells19 Feb 2026US 2026/0048083 A1NKMAX Co., Ltd.
- Bioreactors for perfusing cells29 Jan 2026US 2026/0028571 A1Ramot at Tel-Aviv University Ltd.
- Compositions and methods for producing antibody-generating immune organoids29 Jan 2026US 2026/0028593 A1Parallel Biosystems, Inc.
Most cited
By later US patents
- Artificial immune system: methods for making and use32US 8,288,159 B2Sanofi Pasteur Vaxdesign Corp. et al. · 2012
- Methods for antibody production29US 8,298,823 B2Sanofi Pasteur Vaxdesign Corporation · 2012
- Generation of HPV-specific T-cells12US 9,642,906 B2Baylor College of Medicine · 2017
- Method for determining the immunogenicity of an antigen10US 7,785,806 B2Vaxdesign Corporation · 2010
- Artificial immune system: methods for making and use10US 7,855,074 B2Vaxdesign Corporation · 2010